Factors contributing to donor‐specific HLA antibody (DSA) development after lung transplantation have not been systematically evaluated. We hypothesized that the isolation of Pseudomonas aeruginosa in respiratory specimens would increase the risk of DSA development. Our objective was to determine the risk of DSA development associated with the isolation of Pseudomonas aeruginosa after lung transplantation. We conducted a single‐center retrospective cohort study of primary lung transplant recipients and examined risk factors for DSA development using Cox regression models. Of 460 recipients, 205 (45%) developed DSA; the majority developed Class II DSA (n = 175, 85%), and 145 of 205 (71%) developed DSA to HLA‐DQ alleles. Univariate time‐dependent analyses revealed that isolation of Pseudomonas from respiratory specimens, acute cellular rejection, and lymphocytic bronchiolitis are associated with an increased risk of DSA development. In multivariable analyses, Pseudomonas isolation, acute cellular rejection, and lymphocytic bronchiolitis remained independent risk factors for DSA development. Additionally, there was a direct association between the number of positive Pseudomonas cultures and the risk of DSA development. Our findings suggest that pro‐inflammatory events including acute cellular rejection, lymphocytic bronchiolitis, and Pseudomonas isolation after transplantation are associated with an increased risk of DSA development.
Murine models are currently the preferred approach for studying the molecular mechanisms of cardiac dysfunction resulting from changes in gene expression. Transgenic and gene-targeting methods can be used to generate mice with altered cardiac size and function, and as a result, in vivo techniques are indispensible in evaluating cardiac phenotype. Traditionally, the pathologic assessment of sacrificed hearts was used to study cardiac pathophysiology in small animals. Below we describe the use of ultrasound biomicroscopy-Doppler analysis to temporally assess cardiac function in mouse embryos. Methods are described for obtaining 2D, pulsed-wave Doppler, and M-mode imaging using standard clinical cardiac ultrasound imaging planes.
Introduction:
The physiologic relevance of myocardial bridging (MB) that is found on invasive (ICA) and CT coronary angiography (CTA) is not known. Myocardial perfusion imaging (MPI) may be useful in objectively assessing altered myocardial blood flow associated with MB. We studied the prevalence of ischemia on MPI and mortality among patients with MB.
Methods:
Patients with MPI studies within 6 months of MB identified on ICAs (2002-2014) or CTAs (2005-2014) at the Mayo Clinic were retrospectively studied. Exclusion criteria included a history of myocardial infarction (MI), coronary artery bypass grafting and hemodynamically significant coronary artery disease (CAD, coronary artery stenosis ≥ 50%) were excluded.
Results:
1116 individuals had MB on ICA out of which 300 had MPI studies. 511 individuals had MB on CTA out of which 63 had MPI studies. After excluding patients with CAD, 114 patients with MB identified on ICA and 31 patients with MB identified on CTA remained for analysis. Patients in the ICA and CTA cohort were the same age (60±13 years for ICA vs 60±12 years for CTA cohort, p=0.9). The ICA cohort was likely to include smokers (47 vs 26%, p=0.03) and those with hyperlipidemia (67 vs 45%, p=0.03). The prevalence of ischemia on MPI was similar in the ICA and CTA cohorts (42 vs. 44%, p=0.5). After a median follow-up of 1166 days, the ICA cohort had 12 patient deaths (8%). There was no death in the CTA cohort. The presence of ischemia on MPI was not associated with increased mortality on long-term follow-up (Log Rank p=0.9).
Conclusions:
Ischemia on MPI is commonly found in patients with MB who do not have significant CAD. While patients with MB identified on ICA are more likely to have traditional CAD risk factors, the prevalence of ischemia on MPI was similar when compared to patients with MB on CTA. In this small retrospective study, ischemia identified on MPI was not associated with increased mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.